Skip to Main Content

Paper Details

Reply to the Letter to the Editor 'Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification' by Hannoun-Levi et al.
Ann Oncol
0
2022
Author NameAffiliation
Meredith M ReganDana-Farber Cancer Institute, Harvard Medical School
Giuseppe CuriglianoUniversity of Milan, European Institute of Oncology, IRCCS
  • 1 - 2

Datasets

Release 1.2